A Long Road to an RSV Antibody to Protect the Most Vulnerable
This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born a micro preemie at under 26 weeks, little Alistair…
